6505--Radiopharmaceuticals RMR VAMC 5-year IDIQ
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 19, has awarded a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract for Radiopharmaceuticals to CARDINAL HEALTH 414, LLC. This 5-year contract supports the VA Eastern Colorado Healthcare System (VA ECHCS) at the Rocky Mountain Regional VAMC in Aurora, CO. The award, under solicitation number 36C25926Q0144, was made on January 29, 2026, with an initial stated award amount of $0.00, but includes a guaranteed minimum of $4,000.00 and a maximum contract value of $3,000,000.00.
Scope of Work
The contract requires the provision of various radiopharmaceuticals and related services, including kits (Pyrophosphate, Ultratag) and unit doses of numerous radiopharmaceuticals such as filtered sulfur colloid, MAA, mebrofenin, bulk technetium, F-18 FDG, and others. Services include 24/7 ordering availability, up to two weekday deliveries, and STAT orders delivered within 90 minutes. The contractor must comply with Title 10 CFR, USP 797/825, NRC, NHPP, DOT, and FDA regulations, as well as VA information security and privacy requirements. Delivery is FOB Destination to the Rocky Mountain Regional VA Medical Center.
Contract Details
- Awardee: CARDINAL HEALTH 414, LLC (UEI CWN9UGL3NCL9), 7000 CARDINAL PL, DUBLIN, OH 43017
- Award Number: 36C25926D0018
- Contract Type: Firm-Fixed Price IDIQ
- Duration: Five (5) one-year ordering periods, from February 1, 2026, to January 31, 2031.
- Award Amount: $0.00 (initial stated award amount), with a guaranteed minimum of $4,000.00 and a maximum contract value of $3,000,000.00 over the life of the contract.
- Set-Aside: Unrestricted
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing), Size Standard: 1,300 Employees
- PSC: 6505 (Drugs And Biologicals)
Evaluation & Award
The award was made on an "All or Nothing Basis" following an evaluation of technical capability, price, completion of the FAR 52.225-2 Buy American Certificate, and past performance (requiring at least three recent and relevant references). The government confirmed a sole award and did not separate high and low energy radiopharmaceutical products.
Key Dates
- Award Date: January 29, 2026
- Original Proposal Submission Deadline: January 20, 2026, 2:00 PM ET
- Original Questions Deadline: January 14, 2026, 12:00 AM ET
Contact Information
For official communications, the Contract Specialist is Chris Hollingsworth at Christopher.Hollingsworth2@va.gov or (303)712-5724. Authorized government points of contact include COR Amy Ipson and POCs Mario Hernandez, Orla Erickson, Irena Kovalenkiene, and Jason Murphy.